» Articles » PMID: 12389007

Pregnancy Outcome of Female Survivors of Childhood Cancer: a Report from the Childhood Cancer Survivor Study

Overview
Publisher Elsevier
Date 2002 Oct 22
PMID 12389007
Citations 98
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study was undertaken to determine the effect, if any, of prior treatment with radiation therapy or chemotherapy for cancer diagnosed during childhood or adolescence on pregnancy loss, live births, and birth weight.

Study Design: We reviewed pregnancy outcome among female participants in the Childhood Cancer Survivor Study (CCSS) who returned a questionnaire. Eligibility for the CCSS included 5-year survivors who were <21 years old at diagnosis and who were diagnosed with an eligible cancer between January 1, 1970, and December 31, 1986, at the 25 participating CCSS institutions. The questionnaire included items regarding attempts to become pregnant, the occurrence of pregnancy, and the outcome of pregnancy (ie, live birth, stillbirth, miscarriage, abortion). Medical records of all members of the cohort were abstracted to obtain chemotherapeutic agents administered, the cumulative dose of drug administered for several drugs of interest, and the doses, anatomic regions, and dates of administration of all radiation therapy.

Results: One thousand nine hundred fifteen females reported 4029 pregnancies (63% live births, 1% stillbirths, 15% miscarriages, 17% abortions, 3% unknown or in gestation). There were no significant differences in pregnancy outcome by treatment. A higher, but not statistically significant, risk of miscarriage was present among women whose ovaries were in the radiation therapy field (relative risk [RR] 1.86, P =.14), were near the radiation therapy field (RR 1.64, P =.06), or were shielded (RR 0.90, P =.88). The rate of live birth was not lower for the patients treated with any particular chemotherapeutic agent. The offspring of the patients who received pelvic irradiation were more likely to weigh <2500 g at birth (RR 1.84, P =.03).

Conclusions: This large study did not identify adverse pregnancy outcomes for female survivors treated with most chemotherapeutic agents. The offspring of women who received pelvic irradiation are at risk for low birth weight.

Citing Articles

Molecular Mechanisms Determining Mammalian Oocyte Quality with the Treatment of Cancer Therapy.

Dong R, Abazarikia A, Luan Y, Yu S, Kim S Adv Anat Embryol Cell Biol. 2024; 238:97-119.

PMID: 39030356 DOI: 10.1007/978-3-031-55163-5_5.


Assisted reproductive technology use and outcomes in childhood cancer survivors.

Keefe K, Lanes A, Stratton K, Green D, Chow E, Oeffinger K Cancer. 2023; 130(1):128-139.

PMID: 37732943 PMC: 10841316. DOI: 10.1002/cncr.34995.


Clinical and self-reported markers of reproductive function in female survivors of childhood Hodgkin lymphoma.

Drechsel K, Broer S, Stoutjesdijk F, Twisk J, van den Berg M, Lambalk C J Cancer Res Clin Oncol. 2023; 149(15):13677-13695.

PMID: 37522923 PMC: 10590326. DOI: 10.1007/s00432-023-05035-z.


Radiation therapy of cancer in the adolescent and young adult (AYA) generation.

Soejima T Jpn J Radiol. 2023; 41(12):1331-1334.

PMID: 37440159 DOI: 10.1007/s11604-023-01461-8.


Clinical Challenges in the Management of Malignant Ovarian Germ Cell Tumours.

Saani I, Raj N, Sood R, Ansari S, Mandviwala H, Sanchez E Int J Environ Res Public Health. 2023; 20(12).

PMID: 37372675 PMC: 10298722. DOI: 10.3390/ijerph20126089.